Labshake search
Citations for Lonza :
1 - 50 of 1227 citations for Recombinant Human Interleukin 3 Receptor Alpha Low Affinity His tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2024Quote: ... and recombinant human insulin 0.5%) (Lonza). Human cervical cancer cell line SiHa from ATCC (ATCC® HTB-35™ ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant insulin (20 μg/mL, Lonza, #BE03-033E20), human recombinant EGF (2 ng/mL ...
-
bioRxiv - Biophysics 2020Quote: ... hydrocortisone and recombinant human epidermal growth factor (MEGM Bullet Kit CC-4136; Lonza). Cells were maintained in an incubator under standard conditions (36.5 °C ...
-
bioRxiv - Cell Biology 2023Quote: ... PCR products were separated by 3% low melting agarose gel (Lonza, cat#50111) and detected with Gel Image System (Tanon 1600) ...
-
bioRxiv - Neuroscience 2023Quote: Larvae were anesthetized with 0.02% ethyl 3-aminobenzoate methanesulfonate salt (Tricane, (E10521, Ethyl 3-aminobenzoate methanesulfonate) and mounted in 1% low melting point agarose (50100, Lonza) in a 60 mm x 15 mm petri dish ...
-
bioRxiv - Molecular Biology 2022Quote: ... 3 × 107 cells per plug were embedded in 0.4% SeaPlaque low-melting-point agarose (Lonza) and in the presence of 75 mM EDTA ...
-
bioRxiv - Immunology 2021Quote: Commercially available human primary PTs from 6 donors (3 males and 3 females, Lonza Walkersville Inc) were expanded at passage 4 ...
-
bioRxiv - Developmental Biology 2020Quote: ... The cell suspensions were mixed with ultra low melting agarose solution (3% SeaPrep®, LONZA, #50302) in a volume ratio of 1:1 and were loaded onto the two aqueous phase inlets of the FFD ...
-
bioRxiv - Genetics 2021Quote: ... RNPs containing recombinant CRISPR/Cas9 and sgRNA were transfected to human cell lines using a Nucleofector (Lonza). Stable cell lines were generated by selection of hygrogmycin resistance ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... 100 μg/ml streptomycin and 15 ng/ml recombinant human macrophage colony stimulating factor (Lonza, Melbourne, Australia) on 10 mm square dishes (Bio-strategy ...
-
bioRxiv - Immunology 2021Quote: ... Human Umbilical Venous Endothelial Cells (HUVEC; pooled from 3 individual donors; LONZA) were starved for 6 h ...
-
bioRxiv - Immunology 2023Quote: Low passage primary human bronchial epithelial cells (HBEC) from healthy adult donors were obtained commercially (Lonza, Walkersville, MD, USA) and cultured at air-liquid interface according to the manufacturer’s instructions (Stem Cell Technologies ...
-
bioRxiv - Biochemistry 2021Quote: ... 100 μg ml−1 streptomycin and 15 ng ml−1 recombinant human macrophage colony stimulating factor (Lonza, Melbourne, Australia) on 10 mm square dishes (Bio-strategy ...
-
Synthetic lethal targeting of TET2-mutant hematopoietic stem and progenitor cells by XPO1 inhibitorsbioRxiv - Cancer Biology 2022Quote: ... or either of two different gRNAs targeting exon 3 coding sequences of human TET2 (TET2-gRNA #1: 5’-TGGAGAAAGACGTAACTTC-3’ and TET2-gRNA #2: 5’-TCTGCCCTGAGGTATGCGAT-3’) were transfected with Nucleofector (Lonza). After transduction ...
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with 0.1 μg/ml of interleukin (IL)-34 (IL-34) (Lonza, Basel-Stadt, Switzerland), 0.01 μg/ml of granulocyte-macrophage colony-stimulating factor (GM-CSF ...
-
bioRxiv - Cell Biology 2023Quote: ... supplemented with 0.1 μg/mL of interleukin (IL)-34 (IL-34) (Lonza, Basel-Stadt, Switzerland), 0.01 μg/mL of granulocyte-macrophage colony-stimulating factor (GM-CSF ...
-
bioRxiv - Bioengineering 2022Quote: ... Human umbilical vein endothelial cells (HUVECS; C2519A) were cultured in EGM-3 medium (Lonza) and were used passages 2-3 for organoids fabrication ...
-
bioRxiv - Cancer Biology 2023Quote: ... (v) human neonatal dermal fibroblast cell lines NDF-2 and NDF-3 (#CC-2509; Lonza Bioscience ...
-
bioRxiv - Developmental Biology 2022Quote: Low melting-point agarose (Lonza) was mixed with PBS ...
-
bioRxiv - Microbiology 2020Quote: Low-melt agarose (Lonza, 50101) and carrageenan (Sigma ...
-
bioRxiv - Biophysics 2021Quote: Commercially available primary human umbilical vein endothelial cells (HUVECs) (pooled, passages 3-5, Lonza, Basel, Switzerland) were grown in EGM-2 medium (Lonza ...
-
bioRxiv - Bioengineering 2020Quote: Low melt agarose (Lonza SeaPlaque 50105) was dissolved at twice the concentration required and kept at 37°C to prevent polymerisation ...
-
bioRxiv - Bioengineering 2020Quote: Low melt agarose (Lonza SeaPlaque 50105) was dissolved at twice the required concentration (2% ...
-
bioRxiv - Cell Biology 2021Quote: ... in 1.5% low-melt agarose (Lonza) and cleared overnight using Ce3D 51 ...
-
bioRxiv - Cancer Biology 2023Quote: Sterile low melting agarose (SeaPlaque, Lonza) was prepared at 5% stock concentration with 1% final concentration (bottom layer ...
-
bioRxiv - Cell Biology 2023Quote: ... FADS 1 cells were grown in MEM Alpha (Lonza, Basel, Switzerland) supplemented with 15% FBS and 1% pen/strep ...
-
bioRxiv - Bioengineering 2023Quote: ... 5- 10 mL alpha-Minimum Essential Medium (α-MEM, Lonza, UK) or Dulbecco’s Modified Eagle Medium (DMEM ...
-
bioRxiv - Bioengineering 2023Quote: ... 5-10 mL alpha-Minimum Essential Medium (α-MEM, Lonza, UK) or Dulbecco’s Modified Eagle Medium (DMEM ...
-
bioRxiv - Molecular Biology 2019Quote: ... before: DMEM-low glucose (Lonza, Vienna, Austria) containing 10% fetal calf serum (FCS ...
-
bioRxiv - Cancer Biology 2021Quote: ... A 0.5% low melting point agarose (Lonza) solution in complete medium was used as bottom layer in 6-well flat bottom plates (Falcon®) ...
-
bioRxiv - Cancer Biology 2022Quote: ... new medium (DMEM low glucose from Lonza, supplemented with 1% rabbit complement sera from Sigma-Aldrich ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... using 0.6% low-melting-point agarose (Lonza) containing 0.014% tricaine ...
-
bioRxiv - Biochemistry 2023Quote: ... A 0.5% low melting point agarose (Lonza) solution in complete medium was used as bottom layer in 6- well flat bottom plates ...
-
bioRxiv - Microbiology 2021Quote: ... The human lung epithelial cell line Calu-3 (ATCC HTB-55) was maintained in DMEM F-12 (Lonza) supplemented with 10% FBS ...
-
bioRxiv - Immunology 2023Quote: ... beads were removed on day 3 followed by electroporation using the Human T Cell Nucleofector™ Kit (Lonza) and the Amaxa Nucleofactor® 2b (Lonza ...
-
bioRxiv - Microbiology 2022Quote: ... for 24 h then interleukin-2 (50U/ml) for 4-6 days before nucleofection (as recommended by the manufacturer, Lonza) or infection by HIV-1.
-
bioRxiv - Immunology 2019Quote: ... washed once in PBS and resuspended in Mouse B cell Nucleofector Solution with Supplement (murine B cells) or Primary Cell Nucleofector Solution 3 with Supplement (human B cells) prepared to the manufacturer’s instructions (Lonza) at a concentration of 4 - 5 × 106 cells / 86 μL ...
-
bioRxiv - Cell Biology 2022Quote: Human umbilical vein endothelial cells (HUVEC) were cultured between passage 3 and 6 in EGM-2 complete medium (Lonza)3,52–55 ...
-
bioRxiv - Cell Biology 2022Quote: Normal human bronchial epithelial cells (HBECs) from 3 independent donors (Supplemental Table S1) were obtained from Lonza (CC-2540) and cultured in BEGM growth media (Lonza CC-3170) ...
-
bioRxiv - Cancer Biology 2024Quote: ... and (iv) the NDF-2 and NDF-3 cell lines (human neonatal dermal fibroblast cell lines, #CC-2509; Lonza Bioscience ...
-
bioRxiv - Bioengineering 2019Quote: Bioharmonophores were immobilized in low melting agarose by mixing 200 μL bioharmonophore with 100 μL 1% SeaPlaque low melting agarose (Lonza) solution in 8-well imaging chambers (Lab-Tek) ...
-
bioRxiv - Neuroscience 2021Quote: ... containing 4% low melting point agarose (50111, Lonza) which was then allowed to solidify at 4°C for a few minutes ...
-
bioRxiv - Biochemistry 2019Quote: Low-melting agarose (e.g. SeaPlaque® agarose, Lonza)
-
bioRxiv - Cancer Biology 2020Quote: ... and embedded in 4% low-melting agarose (Lonza) preheated at 42 °C ...
-
bioRxiv - Genetics 2020Quote: ... ∼1×106 cells were transfected with pairs of 5 µg gRNA plasmid and 4 µg ssODN (Supplementary Table 3) using AmaxaTM Human CD34 Cell NucleofectorTM Kit (Lonza) in the 2B-NucleofectorTM on the U-08 setting ...
-
bioRxiv - Cell Biology 2022Quote: ... and diseased COPD human lung fibroblasts (DHLFs) from 3 donors (donor IDs: OF3353, OF3418 and OF3238) were purchased from Lonza and tested for their response to FGF2 and TGFβ stimulation.
-
bioRxiv - Microbiology 2021Quote: ... The human lung epithelial cell line Calu-3 (ATCC HTB-55) was maintained in DMEM F-12 (Lonza, Basel, Switzerland) supplemented with 10% FBS ...
-
bioRxiv - Developmental Biology 2022Quote: ... and mounted in 1 % Low-Melt Agarose (Lonza, 50080) and imaged on a glass bottom FluoroDish™ (WPI FD3510-100 ...
-
bioRxiv - Biophysics 2022Quote: ... mixed with 0.045g SeaPlaque low melting Agarose (Lonza, Switzerland), heated for 20 seconds and allowed to cool for 25 minutes]32 ...
-
bioRxiv - Microbiology 2023Quote: ... The concentration of low melting agarose (SeaKem LE, Lonza) for plug preparation was reduced to 0.8% and lysozyme (1 mg/mL ...